big orange Saturday, 11/02/19 12:35:12 PM Re: noretreat post# 1058 Post # of 1085 My concern is that there will need to be further phase three studies on the secondary end points. Listened to the archived October 31 presentation. Appears that a lot of promising information is to be presented at the AHA meeting with no FDA approval.